NCDActive
Percutaneous Image-Guided Breast Biopsy
NCD272
Effective: January 1, 2003
Updated: December 31, 2025
Policy Summary
Medicare covers percutaneous image-guided (stereotactic or ultrasound) breast biopsy for non-palpable radiographic abnormalities graded BIRADS III, IV, or V and for palpable lesions that are difficult to biopsy by palpation alone. Coverage is limited to stereotactic or ultrasound guidance, excludes BIRADS I–II non-palpable findings, and the determination of which palpable lesions qualify is at the Medicare Administrative Contractor's discretion.
Coverage Criteria Preview
Key requirements from the full policy
"Medicare covers percutaneous image-guided breast biopsy (stereotactic or ultrasound) for non-palpable radiographic breast abnormalities graded BIRADS III, IV, or V."
Sign up to see full coverage criteria, indications, and limitations.